<code id='582772F2E8'></code><style id='582772F2E8'></style>
    • <acronym id='582772F2E8'></acronym>
      <center id='582772F2E8'><center id='582772F2E8'><tfoot id='582772F2E8'></tfoot></center><abbr id='582772F2E8'><dir id='582772F2E8'><tfoot id='582772F2E8'></tfoot><noframes id='582772F2E8'>

    • <optgroup id='582772F2E8'><strike id='582772F2E8'><sup id='582772F2E8'></sup></strike><code id='582772F2E8'></code></optgroup>
        1. <b id='582772F2E8'><label id='582772F2E8'><select id='582772F2E8'><dt id='582772F2E8'><span id='582772F2E8'></span></dt></select></label></b><u id='582772F2E8'></u>
          <i id='582772F2E8'><strike id='582772F2E8'><tt id='582772F2E8'><pre id='582772F2E8'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:32
          Medicare is planning to send $9 billion in lump sum payments to more than 1,600 hospitals that participate in a drug discount program. Adobe

          WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          To pay for the restitution, Medicare would slash all hospitals’ payments for other items and services by 0.5% for the next 16 years.

          advertisement

          The remedy accounts for four years of underpayments to hospitals that participate in the 340B drug discount program. The Trump administration dramatically reduced Medicare payments for discounted drugs in 2018, but the Supreme Court found they didn’t follow the proper procedure and that the payment scheme was illegal.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          FDA approves Leqembi, a milestone in Alzheimer’s treatment
          FDA approves Leqembi, a milestone in Alzheimer’s treatment

          Amyloidplaquesformingbetweenneurons.AdobeTheFoodandDrugAdministrationonThursdaygrantedfullapprovalto

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

          1:10PresidentJoeBidenparticipatesinaceremonialarrivalandinspectionofthehonorguardwithBritain'sKingCh